Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this warning letter issued to Farmville Discount Drug, Inc. (operating as Best Value Drug) in July 2019 concerns drug product violations, though the specific nature of the violations cannot be determined without access to the full letter text. The FDA took action against this pharmacy or drug distributor operation, indicating potential compliance issues within the drugs product category. Without the detailed subject line and specific violation count, the precise regulatory concerns—whether related to manufacturing practices, product quality, distribution, or other drug-related requirements—remain unclear from this metadata alone.